Fresenius Medical Care AG reported €19.6B of revenue over the trailing twelve months, +1.5% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: €19.6B (to Q4 2025). Net income: €978M, trailing twelve months to Q4 2025. Operating margin: 9.3%, trailing twelve months to Q4 2025. EPS: €3.37, trailing twelve months to Q4 2025.

FMSFresenius Medical Care AG

Healthcare

$21.06-13% 1Y

$21.06

$19.4152 weeks$26.35

FMS as reported

Fresenius Medical Care AG reported €19.6B of revenue over the trailing twelve months, +1.5% on the year before. 10 reported series are charted on this page, each one as filed.

€19.6B

Revenue, trailing twelve months · to Q4 2025 · +1.5% against the twelve months before

Net income: €978M
Net income · +82% year on year · trailing twelve months to Q4 2025
Operating margin: 9.3%
Operating margin · trailing twelve months to Q4 2025
EPS: €3.37
EPS · +84% year on year · trailing twelve months to Q4 2025

Details›

Every series Ryufin has for FMS, trailing twelve months
Series	Latest	Year on year	As of
Revenue	€19.6B	+1.5%	Q4 2025
Net income	€978M	+82%	Q4 2025
EPS	€3.37	+84%	Q4 2025
Gross margin	26%	n/a	Q4 2025
Operating margin	9.3%	n/a	Q4 2025
Net margin	5.0%	n/a	Q4 2025
ROE	5.5%	n/a	Q4 2025
ROA	2.4%	n/a	Q4 2025
ROIC	6.7%	n/a	Q4 2025
Free cash flow	€3.03B	n/a	Q4 2020 · 20 quarters behind

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.